Dallas Cowboys defensive lineman David Irving faces a possible four-game suspension for the use of performance-enhancing drugs, according to NFL insider Ian Rapoport and local media reports.
Rapoport reported on Twitter that a possible failed test stemmed from supplements Irving was taking and even marketing.
#Cowboys pass-rusher David Irving is facing a 4-game PED suspension, sources say. Stems from a supplement that he had a marketing deal with.
— Ian Rapoport (@RapSheet) May 23, 2017
Mike Fisher with 105.3 The Fan reported there could be an “accidental” nature to the failed test.
Re Irving: great debate re substance, its nature, its origin. (Over-counter but banned?) And player's naive intent. No debate: failed test
— mike fisher ✭ (@fishsports) May 23, 2017
Irving logged 12 tackles, four sacks and four force fumbles in limited playing time in 2016, including standout performances in weeks 6, 15 and 16. He recorded a sack-and-a-half in week 15 against Tampa Bay and again the following week against Detroit.
This offseason, Irving signed a one-year, $615,000 contract. He’ll count just $470,294 against the cap, according to contracts database Spotrac.
Fisher reported that Irving was meeting with Cowboys officials Tuesday morning. An appeal of any suspension Irving receives would be likely.
